Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Form Health vs Levers Health

Form Health
Graded #323

Higher grade

vs+7.100000000000001
Levers Health
Graded #469

Lower grade

The verdict

Form Health takes it — 60.4/100 to 53.3/100.

Form Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Brand-name only telehealth provider offering Wegovy, Ozempic, and Mounjaro at standard pharmacy pricing with physician oversight.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLevers Health +6
28
34
Dose & formulationForm Health +23
77
54
Clinical oversightForm Health +15
86
71
Labs & monitoringLevers Health +1
52
53
FulfillmentForm Health +19
81
62
Contract termsLevers Health +14
41
55
Form Health · left barLevers Health · right bar

The numbers

MetricForm HealthLevers Health
WeighScore60.4/10053.3/100
GradeCC
Scorecard rank#323#469
Semaglutide$1,350/mo (starting dose, brand-name)$247/mo (1.25 mg dose, compounded)
Tirzepatide$1,350/mo (starting dose, brand-name)$296/mo (5 mg dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Form Health

Graded #323 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Brand-name FDA-approved medications

Where it loses points

  • Higher brand-name pricing only
  • Premium pricing relative to market
Levers Health

Graded #469 · C

Strengths

  • Named LLC entity
  • Microdose GLP-1 option marketed for longevity
  • Both semaglutide and tirzepatide available

Where it loses points

  • No LegitScript or PCAB accreditation
  • No physical address disclosed
  • State availability not disclosed
  • FAQ and terms pages return 404
  • Above-average pricing ($247-$396/mo); tirzepatide any-dose plan is $396/mo (only the up-to-5mg low-dose plan is $296)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard